The four TCGA-based molecular prognostic groups of endometrial carcinoma (EC), ie, POLE-
mutant, mismatch repair (MMR)-deficient, p53-abnormal, and “no specific molecular …

Simple Summary Endometrial cancer (EC) is the most common gynaecologic malignancy in
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …

Endometriosis is a gynecological disorder among reproductive-aged women. Recent
epidemiological investigations suggest endometriosis increases the risk of endometrial …

Simple Summary New data, the development of new methods of treatment and management
and the rising incidence of endometrial cancer require constant reviewing, in order to inform …

Endometrial cancer (EC) is the most common gynaecologic malignancy in the developed
countries. Recent evidence suggests that histopathological subtyping together with …

Background When determining adjuvant treatment for endometrial cancer, the decision
typically relies on factors such as cancer stage, histologic grade, subtype, and a few …

Endometrial cancer (EC) is the most common gynecological neoplasm in high-income
countries. Five-year survival rates are related to stage at diagnosis, but currently, no …

One emerging problem for onco-gynecologists is the incidence of premenopausal patients
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …

Clear cell endometrial carcinoma represents an uncommon and poorly understood entity.
Data from molecular/genomic profiling highlighted the importance of various signatures in …

Objective This study used histopathological image features to predict molecular features,
and combined with multi-dimensional omics data to predict overall survival (OS) in high …